Browsing: from

The Lancet Diabetes & Endocrinology Commission redefined obesity by considering both anthropometric and direct measures of adiposity, in addition to body mass index (BMI), and distinguishing preclinical from clinical obesity based on physical function and related conditions. However, the frequency and determinants of progression from preclinical to clinical obesity have never been studied

ASU researchers used AI to analyze antibodies already present in the blood, uncovering patterns that may reveal a person’s “immune readiness” before vaccination. The findings could eventually help identify who is likely to mount a strong response — and who may need additional protection. Graphic by Jason Drees/ASU

Aug 20 (Reuters) – Danish biosolutions maker Novonesis expects results in the second half of 2027 from research with Novo Nordisk into whether microbiome supplements could provide additional benefits alongside GLP-1 weight-loss drugs, its chief executive told Reuters